The NF-κB signaling has been shown to facilitate oncogenic transformation, maintain the aggressiveness of cancerous cells, and more importantly, enhance the tumor microenvironment (TME) by sustaining and/or expanding the GSC population [10,11,12]. The gene discussed is NFKB1; the disease is neoplasm.